Literature DB >> 16887992

Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation.

Carolina Otero1, Marcus Groettrup, Daniel F Legler.   

Abstract

The chemokine receptor CCR7 and its ligands CCL19 and CCL21 play a crucial role for the homing of lymphocytes and dendritic cells to secondary lymphoid tissues. Nevertheless, how CCR7 senses the gradient of chemokines and how migration is terminated are poorly understood. In this study, we demonstrate that CCR7(-GFP) is endocytosed into early endosomes containing transferrin receptor upon CCL19 binding, but less upon CCL21 triggering. Internalization of CCR7 was independent of lipid rafts but relied on dynamin and Eps15 and was inhibited by hypertonic sucrose, suggesting clathrin-dependent endocytosis. After chemokine removal, internalized CCR7 recycled back to the plasma membrane and was able to mediate migration again. In contrast, internalized CCL19 was sorted to lysosomes for degradation, showing opposite fate for endocytosed CCR7 and its ligand.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887992     DOI: 10.4049/jimmunol.177.4.2314

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis.

Authors:  Eóin N McNamee; Joanne C Masterson; Paul Jedlicka; Colm B Collins; Ifor R Williams; Jesús Rivera-Nieves
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

Review 2.  Endocytic trafficking of chemokine receptors.

Authors:  Adriano Marchese
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

3.  Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Authors:  Melissa A Byers; Psachal A Calloway; Laurie Shannon; Heather D Cunningham; Sarah Smith; Fang Li; Brian C Fassold; Charlotte M Vines
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.

Authors:  Ulrike Haessler; Marco Pisano; Mingming Wu; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

5.  p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.

Authors:  Laura Patrussi; Nagaja Capitani; Francesca Cattaneo; Noemi Manganaro; Alessandra Gamberucci; Federica Frezzato; Veronica Martini; Andrea Visentin; Pier Giuseppe Pelicci; Mario M D'Elios; Livio Trentin; Gianpietro Semenzato; Cosima T Baldari
Journal:  Oncogene       Date:  2018-01-12       Impact factor: 9.867

Review 6.  Emerging concepts and approaches for chemokine-receptor drug discovery.

Authors:  Morgan O'Hayre; Catherina L Salanga; Tracy M Handel; Damon J Hamel
Journal:  Expert Opin Drug Discov       Date:  2010-11       Impact factor: 6.098

7.  Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands.

Authors:  David A Zidar; Jonathan D Violin; Erin J Whalen; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

8.  DC-LAMP+ dendritic cells are recruited to gastric lymphoid follicles in Helicobacter pylori-infected individuals.

Authors:  Malin Hansson; Malin Sundquist; Susanne Hering; B Samuel Lundin; Michael Hermansson; Marianne Quiding-Järbrink
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

9.  Modulation of pulmonary dendritic cell function during mycobacterial infection.

Authors:  Mursalin M Anis; Scott A Fulton; Scott M Reba; Yi Liu; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

10.  Effect of adhesion and chemokine presentation on T-lymphocyte haptokinesis.

Authors:  George A Dominguez; Daniel A Hammer
Journal:  Integr Biol (Camb)       Date:  2014-09       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.